Intra-Cellular Therapies Net income (Q1, 2018)-35.5 M

Intra-Cellular Therapies EBIT (Q1, 2018)-37.1 M

Intra-Cellular Therapies Cash, 31-Mar-201874.4 M

Intra-Cellular Therapies revenue breakdown by business segment: 33.6% from License and collaboration revenue and 66.4% from Grant Revenue

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|---|---|

## Revenue | 2.7 m | 577.3 k | 91.4 k | 330.7 k | 245.8 k |

| (79%) | (84%) | 262% | ||

## R&D expense | 21.2 m | 87.7 m | 93.8 m | 79.4 m | |

## General and administrative expense | 10.3 m | 18.2 m | 24.8 m | 23.7 m | |

## Operating expense total | 31.6 m | 105.9 m | 118.6 m | 103.1 m | |

## EBIT | (26.3 m) | (31 m) | (105.8 m) | (118.3 m) | (102.8 m) |

| (960%) | (5368%) | (115816%) | (35760%) | (41833%) |

## Interest expense | 613 k | 7.1 k | 36.8 k | ||

## Interest income | 29.6 k | 303.9 k | 1 m | 2.9 m | 4 m |

## Pre tax profit | (30.7 m) | (104.8 m) | (115.4 m) | ||

## Income tax expense | (18 k) | 1.6 k | 1.6 k | 1.1 m | (1.1 m) |

## Net Income | (26.9 m) | (30.7 m) | (104.8 m) | (116.4 m) | (97.8 m) |

- Source: Company Filings

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q1, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|

## Revenue | 668 k | 167.8 k | 219.2 k | 124.4 k | 3.3 k | 57.4 k | 124.4 k | 3.3 k | 228.4 k | 4.4 k | 95.3 k | 114.7 k | |

## R&D expense | 4.2 m | 2.8 m | 2.7 m | 4 m | 18.6 m | 17.8 m | 28.5 m | 23.4 m | 25.3 m | 23.9 m | 21.5 m | 12.5 m | 30.7 m |

## General and administrative expense | 1.3 m | 1.9 m | 2.1 m | 2.6 m | 3.8 m | 4 m | 3.9 m | 5.1 m | 6.5 m | 6.3 m | 6.3 m | 6.3 m | 6.4 m |

## Operating expense total | 5.5 m | 4.7 m | 4.8 m | 6.6 m | 22.4 m | 21.7 m | 32.3 m | 28.5 m | 31.8 m | 30.2 m | 27.8 m | 18.7 m | 37.1 m |

## EBIT | (4.8 m) | (4.6 m) | (4.6 m) | (6.5 m) | (22.4 m) | (21.7 m) | (32.3 m) | (28.5 m) | (31.5 m) | (30.2 m) | (27.8 m) | (18.6 m) | (37.1 m) |

| (716%) | (2726%) | (2103%) | (5227%) | (675739%) | (37796%) | (26001%) | (859664%) | (13808%) | (691985%) | (29127%) | (16227%) | |

## Interest expense | 131.9 k | 5 k | 2 k | 5 k | 2 k | 12.3 k | |||||||

## Interest income | 5.6 k | 36.2 k | 80.1 k | 88.1 k | 113.9 k | 179.6 k | 188.9 k | 656.4 k | 709.6 k | 763.9 k | 822.2 k | 857.8 k | 1.6 m |

## Pre tax profit | (26.9 m) | (17.8 m) | (35.5 m) | ||||||||||

## Income tax expense | (832.6 k) | 1.6 k | 1.6 k | ||||||||||

## Net Income | (4.9 m) | (4.5 m) | (4.5 m) | (6.4 m) | (22.3 m) | (21.5 m) | (32.2 m) | (27.8 m) | (30.8 m) | (30.3 m) | (26.9 m) | (17.8 m) | (35.5 m) |

- Source: Company Filings

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|---|---|

## Cash | 35.2 m | 61.3 m | 47.2 m | 48.6 m | 37.8 m |

## Accounts Receivable | 336.3 k | 51.6 k | 30.7 k | 94.3 k | |

## Inventories | 762.2 k | 1.3 m | 8 m | 4 m | |

## Current Assets | 38.2 m | 131 m | 483.3 m | 388.2 m | 469.2 m |

## PP&E | 68.3 k | 54.6 k | 775.5 k | 627.6 k | 1.1 m |

## Total Assets | 38.4 m | 131.1 m | 484.1 m | 388.9 m | 471.5 m |

## Accounts Payable | 3.4 m | 2.1 m | 1.6 m | 3.8 m | 6.2 m |

## Short-term debt | |||||

## Current Liabilities | 6.8 m | 10.6 m | 6.3 m | 10.5 m | 14.2 m |

## Long-term debt | |||||

## Total Liabilities | 13.4 m | 17 m | |||

## Additional Paid-in Capital | 89.2 m | 208.9 m | 669.9 m | 685.3 m | 862.5 m |

## Retained Earnings | (57.6 m) | (88.3 m) | (193 m) | (309.5 m) | (407.2 m) |

## Total Equity | 31.6 m | 120.6 m | 476.2 m | 375.5 m | 454.4 m |

## Financial Leverage | 1.2 x | 1.1 x | 1 x | 1 x | 1 x |

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q1, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|

## Cash | 44.1 m | 143.6 m | 91.1 m | 68.9 m | 100.8 m | 71.4 m | 332.8 m | 37.2 m | 52 m | 200.4 m | 23.6 m | 29.6 m | 74.4 m |

## Accounts Receivable | 251.3 k | 167.8 k | 219.2 k | 124.4 k | 3.3 k | 9.1 k | 51.6 k | 98.2 k | 1.3 k | 68.2 k | 61.9 k | ||

## Current Assets | 47.1 m | 146.4 m | 141.2 m | 137.5 m | 236.5 m | 212.6 m | 512.3 m | 462.9 m | 446.8 m | 541.8 m | 371.6 m | 348.8 m | 443.2 m |

## PP&E | 75.7 k | 65.1 k | 63.9 k | 57.4 k | 559.7 k | 722.1 k | 785.5 k | 731.4 k | 718.7 k | 677.7 k | 605.7 k | 628.9 k | 1.3 m |

## Total Assets | 47.3 m | 146.6 m | 141.3 m | 137.6 m | 237.1 m | 213.4 m | 513.1 m | 463.7 m | 447.6 m | 542.6 m | 372.3 m | 349.5 m | 445.6 m |

## Accounts Payable | 4 m | 2.1 m | 415.8 k | 503.9 k | 4.6 m | 4.9 m | 705 k | 2 m | 3.9 m | 5.4 m | 7.2 m | 1.8 m | 10 m |

## Current Liabilities | 7.8 m | 3.9 m | 2.7 m | 3.6 m | 14.6 m | 9.3 m | 10.4 m | 8.9 m | 19.4 m | 140.7 m | 16.3 m | 7 m | 19.7 m |

## Total Liabilities | 14.8 m | 9.8 m | 11.3 m | 10.9 m | 21.6 m | 143.3 m | 19.3 m | 9.9 m | 22.5 m | ||||

## Additional Paid-in Capital | 89.1 m | 204.8 m | 205.3 m | 207.2 m | 332.9 m | 335.7 m | 666.1 m | 673.7 m | 677.6 m | 681.5 m | 689.7 m | 694.1 m | 867.2 m |

## Retained Earnings | (49.5 m) | (62.1 m) | (66.6 m) | (73.1 m) | (110.5 m) | (132.1 m) | (164.2 m) | (220.9 m) | (251.7 m) | (282 m) | (336.4 m) | (354.2 m) | (442.7 m) |

## Total Equity | 39.6 m | 142.7 m | 138.6 m | 134 m | 222.4 m | 203.6 m | 501.9 m | 452.7 m | 426 m | 399.3 m | 353 m | 339.7 m | 423.2 m |

## Financial Leverage | 1.2 x | 1 x | 1 x | 1 x | 1.1 x | 1 x | 1 x | 1 x | 1.1 x | 1.4 x | 1.1 x | 1 x | 1.1 x |

USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|---|

## Net Income | (30.7 m) | (104.8 m) | (116.4 m) | (97.8 m) |

## Depreciation and Amortization | 25.5 k | 139.6 k | 196.9 k | 213.9 k |

## Accounts Receivable | 284.7 k | 20.9 k | (63.7 k) | 94.3 k |

## Inventories | ||||

## Accounts Payable | (1.3 m) | (419.9 k) | 2.1 m | 2.4 m |

## Cash From Operating Activities | (22.8 m) | (102.3 m) | (91.3 m) | (80.5 m) |

## Purchases of PP&E | (11.8 k) | (860.6 k) | (49 k) | (723.4 k) |

## Cash From Investing Activities | (66.7 m) | (361.8 m) | 92.3 m | (92.7 m) |

## Cash From Financing Activities | 115.7 m | 449.9 m | 477.7 k | 162.4 m |

## Interest Paid | 7.1 k | 7.1 k | 36.8 k | |

## Income Taxes Paid | 45 k | 1 m |

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q1, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|

## Net Income | (4.9 m) | (4.5 m) | (4.5 m) | (6.4 m) | (22.3 m) | (21.5 m) | (32.2 m) | (27.8 m) | (30.8 m) | (30.3 m) | (26.9 m) | (35.5 m) |

## Depreciation and Amortization | 82.5 k | |||||||||||

## Accounts Receivable | 219.2 k | 124.4 k | 3.3 k | 9.1 k | 51.6 k | 98.2 k | 1.3 k | 68.2 k | ||||

## Accounts Payable | 415.8 k | 503.9 k | 4.6 m | 4.9 m | 705 k | 2 m | 3.9 m | 5.4 m | 7.2 m | 3.9 m | ||

## Cash From Operating Activities | (27 m) | |||||||||||

## Purchases of PP&E | (295.1 k) | |||||||||||

## Cash From Investing Activities | 63.3 m | |||||||||||

## Cash From Financing Activities | 337.8 k |

USD | Y, 2018 |
---|---|

## Financial Leverage | 1.1 x |

Report incorrect company information

FY, 2017 | |
---|---|

## Patents and Patent Applications | 80 |

- Source: Company Filings

Report incorrect company information